Leerapun et al. demonstrated that AFP-L3% increased the specificity of HCC diagnosis to 100% in those patients with an indeterminate AFP value (10–200 ng/mL) and an AFP-L3% greater than 35% [67]. The gene discussed is AFP; the disease is hepatocellular carcinoma.